Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-04-02

FDA Approved: DONEPEZIL — Supplemental Application (Quallent Pharmaceuticals Health LLC)

View source ↗

Summary

The FDA approved a supplemental application to market a generic donepezil hydrochloride product from Quallent Pharmaceuticals Health LLC (ANDA 203034).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Donepezil hydrochloride (Donepezil hydrochloride)

Snippet

SUPPL AP for DONEPEZIL (DONEPEZIL HYDROCHLORIDE)